Treatment of hepatocellular carcinoma associated with cirrhosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Treatment of Hepatocellular Carcinoma Associated With Cirrhosis." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451413/all/images/google-play-badge.png.
Treatment of hepatocellular carcinoma associated with cirrhosis. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451413/all/images/google-play-badge.png. Accessed April 27, 2024.
Treatment of hepatocellular carcinoma associated with cirrhosis. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/451413/all/images/google-play-badge.png
Treatment of Hepatocellular Carcinoma Associated With Cirrhosis [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451413/all/images/google-play-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Treatment of hepatocellular carcinoma associated with cirrhosis
ID - 451413
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451413/all/images/google-play-badge.png
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -